FindTrial
Sign In

Recombinant thyrotropin alfa

BIOLOGICAL2 trials

Sponsors

National Cancer Institute (NCI), City of Hope Medical Center

Conditions

Recurrent Thyroid CancerStage IVA Follicular Thyroid CancerStage IVA Papillary Thyroid CancerStage IVB Follicular Thyroid CancerStage IVB Papillary Thyroid CancerStage IVC Follicular Thyroid CancerStage IVC Papillary Thyroid CancerThyroid Gland Follicular Carcinoma

Phase 2

Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131
CompletedNCT00085293
National Cancer Institute (NCI)Recurrent Thyroid Cancer, Stage IVA Follicular Thyroid Cancer, Stage IVA Papillary Thyroid Cancer +4
Start: 2004-05-31End: 2014-05-31Updated: 2018-11-29
Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation
RecruitingNCT06440850
City of Hope Medical CenterThyroid Gland Follicular Carcinoma, Thyroid Gland Oncocytic Carcinoma, Thyroid Gland Papillary Carcinoma
Start: 2024-07-15End: 2026-11-22Target: 21Updated: 2026-02-02